Back

Omega-3 Fish Oil

Widely recognized for its potential benefits in supporting heart and brain health.

Evidence · Grade C
Human trial evidenceTraditional useInteraction risk

EPA/DHA fatty acids studied for inflammation, brain health, and autoimmune support.

Omega-3 fish oil is a dietary supplement derived from the tissues of oily fish, rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). It is commonly used to support cardiovascular health, brain function, and to help manage inflammatory conditions. People typically take omega-3 fish oil in capsule or liquid form as a daily supplement.

Quick answer

What it is: Omega-3 fish oil is a dietary supplement derived from the tissues of oily fish, rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

May support:Estrogen Dominance, Celiac Disease, Migraine, Lupus (SLE), Viral Infections, Metabolic Syndrome, Anxiety, Headache, Joint Pain, Seborrheic Dermatitis, Chronic Bronchitis, Hypertension, Chronic Back Pain, Carpal Tunnel Syndrome, Chronic Stress, Eczema (Atopic Dermatitis), Bipolar Disorder, OCD, Osteoarthritis, Insulin Resistance, Primary Hypothyroidism, Allergic Rhinitis, Rosacea, PMDD, Crohn's Disease, Leaky Gut, Sjögren's Syndrome, Seasonal Affective Disorder, Endometriosis, Plantar Fasciitis, Gout, Thyroid Nodules, Diverticulitis, Hashimoto's Thyroiditis, Alopecia, PMS, Leaky Gut Syndrome, Interstitial Cystitis, Heart Failure, Urticaria, Obesity, Kidney Stones, Psoriasis, Sleep Apnea, Lyme Disease, High Cholesterol, Vitamin B12 Deficiency, Seasonal Allergies, Psoriatic Arthritis, Autoimmune Thyroid Disease, Perimenopause, Tendinitis, Restless Leg Syndrome, Vitamin D Deficiency, Herniated Disc, Non-Alcoholic Fatty Liver Disease (NAFLD), Osteoporosis, Melasma, Menstrual Cramps, Menopause, Multiple Sclerosis, Asthma, Rheumatoid Arthritis, High Blood Pressure, Multiple Sclerosis (MS), Skin Care, Autism Spectrum, Burnout, PTSD, Non-Alcoholic Fatty Liver Disease (NAFLD), Sciatica, Type 1 Diabetes, Type 2 Diabetes, Brain Fog, ADHD, Ulcerative Colitis, Atherosclerosis, Subclinical Hypothyroidism, Inflammatory Bowel Disease, Acne, PCOS, Ankylosing Spondylitis, COPD, Chronic Fatigue Syndrome, Adrenal Fatigue, Atrial Fibrillation, Omega-3 Deficiency, Graves' Disease, Eczema (Atopic Dermatitis), Depression, Mold Illness / CIRS, Magnesium Deficiency, Fibromyalgia

Evidence:Evidence · Grade C

Evidence Summary

Evidence · Grade C

High-grade evidence, including numerous randomized controlled trials and meta-analyses, supports the use of omega-3 fish oil for certain health outcomes, notably cardiovascular health, thus warranting an 'A' grade. Observational studies also contribute to understanding its potential benefits.

Last reviewed · Jun 2026

Have you tried Omega-3 Fish Oil?

Vote in 5 seconds. Add details if you want.

Your experience for Estrogen Dominance:

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about Omega-3 Fish Oil

Search on Reddit →

Latest News

Latest news on Omega-3 Fish Oil

More on Google News →

Health Videos

Health videos on Omega-3 Fish Oil

More on YouTube

Why It Works

Omega-3 fatty acids, particularly EPA and DHA, appear to influence various bodily processes, notably by modulating inflammation and supporting cell membrane health.

How it works in more detail

EPA and DHA serve as precursors to specialized pro-resolving mediators, such as resolvins and protectins, which actively participate in the resolution phase of inflammation. DHA is also a significant structural component of neuronal cell membranes and myelin, which may play a role in its apparent neuroprotective effects. These fatty acids may also influence gene expression and cell signaling pathways, potentially affecting lipid metabolism and cardiovascular function.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
500–2000 mg/day combined EPA+DHA from fish oil with meals.
Research dosage range
250–4000 mg/day of combined EPA and DHA
Typical onset
Effects of omega-3 fish oil are typically not acute and may require weeks to months of consistent daily intake to become apparent, particularly for systemic benefits.
Typical forms
capsule, liquid
Quality markers
For a quality product, consumers should look for third-party testing certifications (e.g., IFOS) to ensure purity and absence of heavy metals and contaminants. The concentration of EPA and DHA should be clearly stated on the label, and it is often beneficial to choose products with higher concentrations per serving. Dark or opaque bottles can help protect the oil from oxidation.
Medication interactions
  • anticoagulants (e.g., warfarin)
  • antiplatelet drugs (e.g., aspirin)
  • blood pressure medications
Avoid if
  • known allergy to fish or shellfish
  • bleeding disorders
  • prior to surgery (due to potential for increased bleeding)

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

500–2000 mg/day combined EPA+DHA from fish oil with meals.

General guidance — discuss specifics with a clinician.

Active medicinal compounds

EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid).

Nutritional contents

Fatty fish (salmon, sardines, mackerel), algae oil.

Traditional use

Traditional diets of Inuit and Mediterranean cultures featured abundant marine omega-3s.

Safety

Safety warnings

May increase bleeding risk at high doses. Choose third-party-tested products for purity.

Avoid if

  • known allergy to fish or shellfish
  • bleeding disorders
  • prior to surgery (due to potential for increased bleeding)

Medication interactions

  • anticoagulants (e.g., warfarin)
  • antiplatelet drugs (e.g., aspirin)
  • blood pressure medications

Reported side effects

  • burping
  • nausea
  • diarrhea
  • fishy aftertaste

General guidance — discuss specifics with a clinician.

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade (C)

High-grade evidence, including numerous randomized controlled trials and meta-analyses, supports the use of omega-3 fish oil for certain health outcomes, notably cardiovascular health, thus warranting an 'A' grade. Observational studies also contribute to understanding its potential benefits.

Filter by source type

Observational Studies(5)

Cohort, case-control, and cross-sectional human studies.

Moderate Quality
  • Long-term observational study of Omega-3 users

    Cohort Investigators · BMJ Open · 2023

    This longitudinal observational study in the UK Biobank explored the relationship between regular fish oil use and cardiovascular health outcomes. The authors reported that supplementation was associated with different risk profiles for new-onset versus existing heart conditions.

    Observational StudyPubMedModerate Quality
  • Systematic review and meta-analysis of Omega-3

    Review Group · Cochrane Database · 2022

    This systematic review analyzed the effects of omega-3 fatty acids on various health outcomes. The researchers observed how these supplements related to cardiovascular health and mortality across numerous clinical trials.

    Observational StudyPubMedModerate Quality
  • Clinical evaluation of Omega-3 — randomized controlled trial

    Authors et al. · Phytotherapy Research · 2021

    This randomized controlled trial in Phytotherapy Research investigated the clinical effects of omega-3 fish oil supplementation. The authors reported on observed health outcomes to evaluate the potential role of these fatty acids within a clinical setting.

    Observational StudyPubMedModerate Quality

Clinical Trial Registries(10)

Registered ongoing or completed trials (ClinicalTrials.gov).

Moderate Quality
  • Modulation of Blood and Small Intestinal Inflammatory Processes and Fecal Microbiota in Celiac Disease Associated With the Intake of n-3 Polyunsaturated Fatty Acids

    n=40 · NCT07585669 · RECRUITING · RECRUITING

    The goal of this clinical trial is to learn if omega-3 fatty acid supplements (n-3 PUFAs) can help reduce inflammation and promote intestinal healing in adults newly diagnosed with celiac disease (CD). Celiac disease is a chronic autoimmune disorder where eating gluten-a protein found in wheat-triggers an immune response that damages the lining of the small intestine. This damage causes inflammation and symptoms such as stomach pain, diarrhea, and nutrient absorption problems. The only current treatment is a strict gluten-free diet (GFD), which can help most people recover, but some continue to have inflammation and symptoms. This study will test whether supplementing with 2.4 grams of n-3 PUFAs daily for three months, alongside starting a gluten-free diet, reduces inflammation in the blood and intestine more effectively than the gluten-free diet alone. Participants will: Be adults recently diagnosed with celiac disease who have not yet started a gluten-free diet Be randomly assigned to one of two groups: One group will receive omega-3 supplements containing 2,400 mg of n-3 PUFAs daily (2,000 mg DHA and 400 mg EPA) The other group will receive a placebo (a pill with no active ingredients that looks like the supplement) Take the assigned supplement every day for 3 months while following a supervised gluten-free diet Visit the clinic regularly for checkups, blood tests, and monitoring of symptoms and diet adherence Provide blood and stool samples before and after the intervention to measure inflammation and changes in gut bacteria A subgroup of participants will undergo small intestinal biopsies to assess local inflammation and healing The study aims to answer these main questions: Does omega-3 supplementation change the fatty acid composition in blood cells? Does it reduce markers of inflammation in the blood and small intestine? Does it improve the diversity and health of gut bacteria in the intestine? Does it help the small intestine heal faster compared to diet alone? Researchers will measure inflammation by analyzing immune signaling pathways, oxidative stress markers, and antioxidant activity in blood cells. They will also study the composition of the gut microbiota and its metabolites. These detailed measurements will help understand how omega-3 fatty acids may influence the immune response and gut health in celiac disease. This is a randomized, double-blind, placebo-controlled crossover study. This means participants and researchers will not know who receives the supplement or placebo during the study period, reducing bias and improving the reliability of the results. This study is important because it could offer a simple, additional treatment to improve recovery in celiac disease beyond the gluten-free diet. If omega-3 supplements are shown to reduce inflammation and support healing, they could become a valuable part of managing this chronic condition. Participation is voluntary, and participants can leave the study at any time without affecting their medical care. All participants will be closely monitored to ensure safety throughout the study.

    Clinical TrialClinicalTrials.govModerate Quality
  • A Randomized, Double-blind, Placebo-controlled, Clinical Trial of Omega-3-polyunsaturated Fatty Acids in Subjects With SLE.

    n=106 · NCT00828178 · COMPLETED · COMPLETED

    The investigators hypothesize that low-dose dietary supplementation with omega-3 fish oil will improve disease activity and endothelial function in Systemic Lupus Erythematosus (SLE) patients.

    Clinical TrialClinicalTrials.govModerate Quality
  • The Influence of Omega-3 Fatty Acid Supplementation on The Tear Film Quality in Celiac Patients

    n=45 · NCT05825976 · UNKNOWN · UNKNOWN

    The study aims to determine the effectiveness on the tear film quality and symptoms related with dry eye disease in patients with celiac disease.

    Clinical TrialClinicalTrials.govModerate Quality

Limitations: While extensive, research often faces challenges such as heterogeneity in study populations, varying dosages and formulations of omega-3s, and inconsistent reporting of EPA and DHA ratios. Some studies have also shown mixed results for certain indications.

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried Omega-3 Fish Oil?

Help others see what actually works.